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STROKE
Introduction
The encouraging trend toward more
individuals surviving stroke creates con-
cern about how these survivors live with
the residual effects. Depression, the most
frequent neuropsychological problem
after stroke, is estimated to affect 25–75%
of survivors at some point in the months
following stroke.1,2 The negative out-
comes associated with post-stroke
depression (PSD) make recognition and
treatment an important aspect of the care
for stroke survivors. Depressive symp-
toms result in less participation in reha-
bilitation, extended recovery time, and
significantly decreased quality of life,
even among stroke survivors with minor
neurological deficits.1,3 Furthermore, PSD
independently increases the risk of post-
stroke mortality and is associated with
increased utilization of health care.4
Although the etiology of PSD is complex
and multifactorial, improvements in the
diagnosis and treatment of this common
problem may be accomplished through




The prevalence of PSD varies widely;
depends on when depressive symptoms
are measured after the stroke; whether
acute care, rehabilitation, or community-
dwelling survivors are of interest; and
which diagnostic criteria are used.6,7 In a
review of 14 studies describing the occur-
rence of major depressive disorder
(MDD) in stroke survivors, the preva-
lence of MDD varied widely across time.
Prevalence rates peaked in the first
months post-stroke, ranging between
9–37%, falling to between 5–16% at 1
year, and increasing again to a rate of
19–21% at 2 years.5 For a large percentage
of stroke survivors who experience
depressive symptoms in the early post-
stroke period, there is a concern that the
symptoms will become chronic. In an 18-
month study, Berg et al.8 found that 46%
of stroke survivors in their sample who
experienced depressive symptoms at 2
months continued to have symptoms
beyond 12 months. This finding is consis-
tent with other studies in which up to
half of stroke survivors, who developed
MDD within the first 7–12 weeks post-
stroke, had lower rates of spontaneous
recovery from depression.5
Impact of Post-Stroke 
Depression
Post-stroke depression, a problem that is
frequently untreated, is linked to negative
outcomes for stroke survivors.1,2 Function-
al outcomes are affected not only in the
Depression, the most frequent neu-
ropsychological problem after stroke,
is greatly influenced by the complex
relationships between the neurobio-
logical and psychological changes
that occur after stroke. Post-stroke
depression leads to negative rehabili-
tation outcomes including less par-
ticipation in therapy, extended recov-
ery time, significantly decreased
quality of life, and increased utiliza-
tion of health care resources. Because
of the high prevalence of post-stroke
depression, all stroke survivors
should be screened early in the reha-
bilitation process. Use of a biopsy-
chosocial framework acknowledges
the multifactorial etiology of post-
stroke depression and contributes to
effective, evidence-based treatment.
Attention to the needs of the family
caregivers further promotes success-
ful post-stroke rehabilitation.




immediate rehabilitation period, but also
over the long term.7 In one small sample
(n = 55), remission of PSD in the first 3 to
6 months post-stroke was associated with
significantly greater recovery of activities
of daily living (ADL) function.9 However,
in a larger study (n = 276), depression at 3
months post-stroke was significantly asso-
ciated with poor functional outcome at 15
months (p< 0.0001).10 Quality of life was
reported to be significantly (p<0.01) lower
among stroke survivors with PSD at 3, 6,
and 12 months post-stroke than among
survivors without PSD and even among
those with significantly (p<0.01) improved
neurological status and limited disability.3
Furthermore, PSD has been associated
with increased mortality;7 it was found
to independently increase the risk of death
by 13% over a 3-year period among
American military veterans.4 This
increased risk of death appeared early in
the rehabilitation period and continued
over time. Finally, as in other groups of
patients with depression, stroke survivors
with PSD have significantly (p<0.0001)
more hospitalizations with longer lengths
of stay and more outpatient visits than




There is ongoing debate as to whether
PSD is a separate diagnosis associated
with a specific neurological insult or a
variation of endogenous depression.
However, PSD can be simply defined as
any depression occurring after stroke.2
Methodological differences among PSD
studies related to time since stroke, diag-
nostic criteria, selection bias, and research
design complicate the attempts to stan-
dardize a definition.2 During the immedi-
ate post-stroke period, a definition based
on diagnostic criteria may be helpful in
differentiating PSD from a more general-
ized response to situational stress. Use of
criteria from the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edi-
tion (DSM-IV) has been recommended in
Over the last 2 weeks, how often have you been Not at all Several More than half Nearly 
bothered by any of the following problems? days the days every day  
(Use “3” to indicate your answer) 
1. Little interest or pleasure in doing things 0 1 2 3  
2. Feeling down, depressed, or hopeless 0 1 2 3  
3. Trouble falling or staying asleep, or sleeping too much 0 1 2 3
4. Feeling tired or having little energy 0 1 2 3
5. Poor appetite or overeating 0 1 2 3
6. Feeling bad about yourself — or that you are a 0 1 2 3
failure or have let yourself or your family down
7. Trouble concentrating on things, such as reading 0 1 2 3
the newspaper or watching television
8. Moving or speaking so slowly that other people 0 1 2 3
could have noticed?  Or the opposite — 
being so fidgety or restless that you have 
been moving around a lot more than usual
9. Thoughts that you would be better off dead or of 0 1 2 3
hurting yourself in some way
(For office coding: Total Score _____  =   ___    +   ___    + ___ )
If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home,
or get along with other people?
Not difficult at all Somewhat difficult Very difficult Extremely difficult 
r r r r
Source: From the Primary Care Evaluation of Mental Disorders Patient Health Questionnaire (PRIME-MD PHQ). PRIME-MD® is a trademark of Pfizer Inc. Copyright©
1999 Pfizer Inc. All rights reserved. Reproduced with permission.
Table 1: PHQ-9 Depression Severity Scale
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the literature.2,7 Although physical symp-
toms of depression, as specified in the
DSM-IV criteria, overlap with common
post-stroke symptoms such as fatigue,
decreased appetite, and sleep distur-
bances, evidence suggests that the use of
DSM-IV criteria for depression does not
lead to either over- or under-diagno-
sis.1,2,7 
Two conflicting hypotheses domi-
nate the literature concerning the etiolo-
gy of PSD.12 The first is that PSD is
primarily neurobiological in nature and
is associated with the location and extent
of the neurological insult.13 The second is
the opposite; PSD is seen primarily as an
endogenous psychological response to
psychosocial stressors associated with
stroke impairment.6 However, given the
complex and inseparable characteristics
of physical and psychiatric illness, Whyte
and Mulsant5 suggest that the debate
between the two hypotheses is unreason-
able. Instead, they suggest a biopsy-
chosocial model in which underlying
vulnerabilities toward depression are
exposed as the neurological and psy-
chosocial effects of stroke decrease an
individual’s affective reserve. This model
proposes that, much like depression in
the general population, PSD develops
from complex relationships between neu-
robiological and psychological factors
and should be considered in the same
manner.5
Evidence from the literature also
suggests that perhaps PSD and depres-
sion in the general population are more
similar than originally thought.6 Ameta-
analysis of 48 studies found no support
for the hypothesis that the risk for PSD is
related to the location of the lesion.14 Any
association between lesion location and
depression has been reported to disap-
pear over the first months post-stroke.12
In a large study (n = 3,371) of communi-
ty-dwelling American adults over the age
of 65 years, no relationships were found
between MRI-identified infarctions and
depression scores after controlling for
age, gender, and stroke history in multi-
ple regression analyses.15 Rather, the
authors concluded, the causal pathway
for depressive symptoms may be related
to the functional consequences of cere-
brovascular disease. In one comparison
study, no differences were found
between depression that occurred follow-
ing myocardial infarction and depression
that occurred after stroke when control-
ling for age, sex, and level of functional
activity limitation.16 In addition, individ-
uals with PSD did not experience more
depression symptoms, although the
physical symptoms of depression were
more severe compared with depressed
older adults without history of stroke.2
Risk Factors for Post-Stroke 
Depression
Methodological inconsistencies and lim-
itations in study design make it difficult
to clearly identify those stroke survivors
who may be at higher risk for developing
depressive symptoms.17 Acknowledging
this difficulty, Whyte and Mulsant5 iden-
tified common risk factors in a systemat-
ic review of English language papers.
Biopsychosocial risk factors linked with
PSD included history of major depres-
sion, disability, stressful life events, poor
social support, and time since stroke.
Recent prospective, multisite studies
present the possibility of quantifying PSD
risk,17 but a clinically useful model
remains elusive.18 The multicentre
DESTRO study attempted to identify and
quantify risk factors for PSD in a large
sample (n = 1,064) of stroke survivors.17
During the study period 36% of the sam-
ple developed PSD primarily in the first
3 months post-stroke. The majority of
survivors with PSD (81%) were diag-
nosed with dysthymia using DSM-IV cri-
teria. Consistent with the literature,
disability and previous depressive
episodes were found to place survivors
at an increased risk of PSD. Additional
risk factors included female sex, previous
psychiatric disorders, and previous cere-
brovascular episodes. Combinations of
these factors exponentially increased the
risk for PSD. The Auckland Regional
Community Stroke (ARCOS) study fol-
lowed 739 stroke survivors to determine
clinically useful predictors of abnormal
mood after stroke.18 After controlling
for age, sex, and comorbidity in a multi-
variate logistic regression analysis, dis-
ability and history of depression were
identified as key baseline predictors of
abnormal mood at 6 months post-stroke.
However, a lack of clinically meaningful
predictive ability limits the usefulness of
this model.18 The findings from the above
literature review and studies emphasize
the multifactorial nature of PSD and the
need to consider biopsychosocial risk fac-
tors similar to other types of depression. 
Screening for Symptoms 
Because PSD can negatively affect reha-
bilitation outcomes, all stroke survivors
should be actively screened for depres-
sive symptoms during the rehabilitation
period.1 A number of standardized
screening tools are available; however, it
is important to consider the purpose of
various tools and whether the tool has
been validated in the stroke population.
The Center for Epidemiology Studies –
Depression (CES-D) and the Beck
Depression Inventory (BDI) are common-
ly used for screening purposes in this
population. However, a tool that is
designed to diagnose and monitor
response to treatment may be more use-
ful in the clinical setting.2,7 The Patient
Health Questionnaire (PHQ)-9 Depres-
sion Severity Scale (shown in Table 1) is
shorter than other tools, can be used to
screen for and diagnose depression, is
sensitive to change, and has been validat-
ed in the stroke population.19 Based on
the nine DSM-IV depression symptoms,
the PHQ-9 is also able to discriminate
between stroke survivors with and with-
out PSD regardless of age, sex, or ethnic-
ity. 




should all be considered in an effort to
stabilize mood, improve participation in
therapy, and improve rehabilitation out-
comes because of the multifactorial
nature of PSD.1 Recent improvements in
functional neuroimaging and neurophys-
iological techniques suggest that recov-
ery from stroke may be potentiated by
www.geriatricsandaging.ca495
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both pharmacological and behavioural
interventions that lead to dynamic
changes in the brain after stroke.20 There
is moderate evidence that interventions
to improve social support for caregivers
also can improve the rehabilitation out-
comes of stroke survivors.21 Further-
more, caregivers are often able to provide
information about PSD symptoms that
stroke survivors may be reluctant to dis-
cuss with their health care providers,
thereby reducing a potential barrier to
treatment.22 
Pharmacological Treatment 
Selective serotonin reuptake inhibitors
(SSRI) and tricyclic antidepressants
(TCA) have been the most frequently
studied antidepressants.1 Post-stroke
depression is reported to be responsive to
either SSRI or TCA, with up to 60% of
stroke survivors responding to these
medications.5 Using SSRI medications
may be preferred for older adults who
have experienced stroke because the side
effect profile is more favourable. Typical-
ly SSRIs have fewer cardiotoxic or anti-
cholinergic side effects than TCAs and
are less likely to cause sedation.1,6 There
is a lack of evidence to support the rou-
tine prophylactic use of antidepressants;
therefore, this practice is not recommend-
ed by clinical practice guidelines.1
Although PSD symptoms respond
to medication, questions arise as to the
effect of pharmacotherapy on depression
remission rates and on rehabilitation out-
comes. Arecent review of seven random-
ized or quasi-randomized placebo-con-
trolled trials concluded that, although
antidepressant treatment reduces symp-
toms, there is no clear effect on remission
of depression and no evidence that anti-
depressant treatment improves function-
al recovery.23 However, the studies in this
review were limited in that the duration
of treatment was shorter than that recom-
mended by the American College of
Physicians guidelines, there was wide
variability in diagnostic criteria, and the
time between stroke onset and enroll-
ment in the trials also varied widely.23
Similarly, Cassidy and colleagues24 con-
cluded that depression severity was not
a significant predictor of rehabilitation
effectiveness as measured by functional
outcomes and that the relationship
between depression and rehabilitation
outcomes may have been masked by
treatment received by 6 of the 10 partici-
pants who were diagnosed with major
depressive disorder. Furthermore, with
the small sample size, there was insuffi-
cient power to determine the effect of
depression on functional outcomes.
Additional research is needed to clarify
these relationships.
Care management and monitoring
of antidepressant therapy may answer
questions about the effectiveness of anti-
depressant medications in reducing and
alleviating the symptoms of PSD. In one
study25 using an activate-initiate-moni-
tor model (AIM), care managers moni-
tored the effectiveness of antidepressant
medications and adherence to the treat-
ment protocol. Medication dosages and
classes were changed as indicated by
patient response using a pre-established
algorithm. Positive depression response
(51% vs. 30%, p = 0.005) and remission
(39% vs. 23%, p = 0.01) were both more
likely in the AIM group than in the usual
care group. A difference in response was
noted by the 6-week assessment and con-
tinued through 12 weeks. Importantly,
this study demonstrates that following
evidence-based guidelines for depression
treatment is associated with significant
improvement in the remission of depres-
sion. Furthermore, the study findings
support the concept that PSD should be
treated similarly to non-stroke-related
depression.25
Psychotherapeutic Interventions 
The evidence for psychotherapeutic
interventions in the reduction and remis-
sion of PSD symptoms is not as strong as
for treatment with antidepressive med-
ication. However, clinical guidelines
report some evidence for the effective-
ness of cognitive-behavioural therapy in
conjunction with antidepressant medica-
tion.  Brief supportive therapy is recom-
mended.1 Cognitive-behavioural therapy
alone shows some promise.6
Social Support Systems 
Support of the caregiver is an emerging
aspect of stroke rehabilitation.20 Clinical
guidelines state that adequate support of
stroke survivors by their family care-
givers and other family members is crit-
ical to successful rehabilitation
outcomes.1,21 However, the levels of psy-
chological distress and morbidity experi-
enced by caregivers are of great concern
and may limit the amount of available
support. Canadian evidence-based prac-
tice standards recommend that stroke
survivors and their caregivers receive
physical help, respite care, and emotion-
al and educational counseling.21 Training
of caregivers has been reported to reduce
overall costs associated with stroke recov-
ery and, in one study, resulted in
improved psychological outcomes and
quality of life for stroke survivors.20 
Due to the high prevalence rate and related negative outcomes, all stroke survivors 
should be screened for post-stroke depression (PSD) during rehabilitation.
The etiology of PSD is multifactorial with both neurobiological and psychosocial 
causes.
Risk factors for PSD include, but are not limited to, level of post-stroke disability, history 
of depression, female sex, and poor social support.
Treatment for PSD is similar to treatment for non-stroke-related depression.
Treatment should be directed by evidence-based guidelines, including pharmacological,
psychotherapeutic, social support, and caregiver support interventions.
Key points
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Conclusion
Despite the heterogeneity of the literature
on identifying and treating PSD, some
conclusions may be drawn about the
appropriate care of stroke survivors expe-
riencing PSD. First, a biopsychosocial
approach to treatment will address both
the physiological and psychological
aspects of depression after stroke. All
stroke survivors should be screened dur-
ing rehabilitation in the first weeks to
months post-stroke because of the high
prevalence of PSD. Patients who have a
positive screen for PSD should be fol-
lowed with a tool that is sensitive to
change over time and should receive evi-
dence-based treatment including phar-
macological, psychotherapeutic, and
social support interventions along with
support for their family caregivers. Early
detection and treatment of PSD may
improve functional outcomes and quali-
ty of life while also reducing the overall
cost of care. 
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